c‐Myc‐mediated epigenetic silencing of MicroRNA‐101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Hepatology

• Publication date

  2014-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/hep.26720PMID 24002871
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MYC on the path to cancer.

  2012cited by this paper
• Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis

  2012cited by this paper
• Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas.

  2012cited by this paper
• Identification of a two-layer regulatory network of proliferation-related microRNAs in hepatoma cells

  2012cited by this paper
• CXCR7/CXCR4 Heterodimer Constitutively Recruits β-Arrestin to Enhance Cell Migration*

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma.

  2011cited by this paper
• Embryonic ectoderm development protein is regulated by microRNAs in human neural tube defects.

  2011cited by this paper
• The Polycomb complex PRC2 and its mark in life

  2011cited by this paper
• Epigenetic repression of the Igk locus by STAT5-mediated recruitment of the histone methyltransferase Ezh2

  2011cited by this paper
• EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies

  2011influential reference
• microRNA involvement in hepatocellular carcinoma.

  2011cited by this paper
• Molecular mechanism of liver cancer.

  2011cited by this paper
• The role of EZH2 in tumour progression

  2011cited by this paper
• Immature myeloid cells accumulate in mouse placenta and promote angiogenesis.

  2011cited by this paper
• Context-Specific Regulation of NFk B Target Gene Expression by EZH 2 in Breast Cancers

  2011cited by this paper
• Aberrations of EZH2 in Cancer

  2011influential reference
• Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer

  2010cited by this paper
• Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway.

  2010cited by this paper
• An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation.

  2009cited by this paper
• MicroRNAs in cancer: small molecules with a huge impact.

  2009cited by this paper
• MicroRNA‐101 regulates expression of the v‐fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma

  2009cited by this paper
• Central role of c-Myc during malignant conversion in human hepatocarcinogenesis.

  2009cited by this paper
• MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity.

  2009cited by this paper
• MicroRNAs: Target Recognition and Regulatory Functions

  2009cited by this paper
• Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expression.

  2009cited by this paper
• Cellular plasticity of trans- and dedifferentiation markers in human hepatoma cells in vitro and in vivo.

  2009cited by this paper
• Polycomb Complex 2 Is Required for E-cadherin Repression by the Snail1 Transcription Factor

  2008cited by this paper
• Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation

  2008cited by this paper
• MicroRNA involvement in hepatocellular carcinoma

  2008cited by this paper
• Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer

  2008cited by this paper
• Widespread microRNA repression by Myc contributes to tumorigenesis

  2008cited by this paper
• Myc-mediated transcriptional repression by recruitment of histone deacetylase.

  2008cited by this paper
• MYC stimulates EZH2 expression by repression of its negative regulator miR-26a.

  2008cited by this paper
• Impaired microRNA processing enhances cellular transformation and tumorigenesis

  2007cited by this paper
• Critical role for NF-kappaB-induced JunB in VEGF regulation and tumor angiogenesis.

  2007cited by this paper
• The Polycomb group protein EZH2 directly controls DNA methylation

  2007cited by this paper
• Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells.

  2007cited by this paper
• Critical role for NF‐κB‐induced JunB in VEGF regulation and tumor angiogenesis

  2007cited by this paper
• Etiology‐dependent molecular mechanisms in human hepatocarcinogenesis

  2007cited by this paper
• Lentivirus‐mediated RNA interference targeting enhancer of zeste homolog 2 inhibits hepatocellular carcinoma growth through down‐regulation of stathmin

  2007cited by this paper
• Indexing Techniques for CHR based on program transformation

  2007cited by this paper
• MicroRNA signatures in human cancers

  2006cited by this paper
• A microRNA expression signature of human solid tumors defines cancer gene targets

  2006cited by this paper
• The global health burden of infection‐associated cancers in the year 2002

  2006cited by this paper
• The Polycomb group protein EZH2 directly controls DNA methylation

  2006cited by this paper
• MicroRNA expression profiles classify human cancers

  2005cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer

  2004cited by this paper
• Involvement of OP18 in cell proliferation.

  1991cited by this paper
• Expression of ras and myc oncogenes in human hepatocellular carcinoma and non-neoplastic liver tissues.

  1989cited by this paper

• Chemical Screening of RIKEN Natural Products Depository Identified a MYCN Expression Inhibitor Partially through HGF-MET Signaling Pathway.

  2026cites this paper
• An update on regulation and function of G protein-coupled receptors in cancer: A promising strategy for cancer therapy.

  2025cites this paper
• Targeting c-MYC has a Key Role in Hepatocellular Carcinoma Therapy.

  2025cites this paper
• EZH2: From Oncogenic Driver to Therapeutic Target for Overcoming Drug Resistance in Hepatocellular Carcinoma

  2025cites this paper
• Isoacteoside alleviates hepatocellular carcinoma progression by inhibiting PDHB-mediated reprogramming of glucose metabolism

  2025cites this paper
• LncRNA SNHG1: A novel biomarker and therapeutic target in hepatocellular carcinoma.

  2025cites this paper
• Growth differentiation factor 7 alleviates the proliferation and metastasis of hepatocellular carcinoma

  2024cites this paper
• Identification of two heterogeneous subtypes of hepatocellular carcinoma with distinct pathway activities and clinical outcomes based on gene set variation analysis

  2024cites this paper
• LncRNA PRKCA-AS1 promotes LUAD progression and function as a ceRNA to regulate S100A16 by sponging miR-508-5p

  2024cites this paper
• Aberrant activation of a miR-101–UBE2D1 axis contributes to the advanced progression and chemotherapy sensitivity in human hepatocellular carcinoma

  2024cites this paper
• Emerging role of MicroRNA-Based theranostics in Hepatocellular Carcinoma

  2023cites this paper
• Repurposing Niclosamide as a Therapeutic Drug against Acute Liver Failure by Suppressing Ferroptosis

  2023cites this paper
• High Tumoral STMN1 Expression Is Associated with Malignant Potential and Poor Prognosis in Patients with Neuroblastoma

  2023cites this paper
• MiRNAs in Alcohol-Related Liver Diseases and Hepatocellular Carcinoma: A Step toward New Therapeutic Approaches?

  2023cites this paper
• Crosstalk between Noncoding RNAs and the Epigenetics Machinery in Pediatric Tumors and Their Microenvironment

  2023cites this paper
• MYC inhibition reprograms tumor immune microenvironment by recruiting T lymphocytes and activating the CD40/CD40L system in osteosarcoma

  2022cites this paper
• MiR-101: An Important Regulator of Gene Expression and Tumor Ecosystem

  2022influential citation
• Tumor suppressor genes are reactivated by miR-26A1 via enhancer reprogramming in NSCLC

  2022cites this paper
• The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment

  2022cites this paper
• Dysregulation of EZH2/miR-138-5p Axis Contributes to Radiosensitivity in Hepatocellular Carcinoma Cell by Downregulating Hypoxia-Inducible Factor 1 Alpha (HIF-1α)

  2022cites this paper
• Noncoding RNAs in liver cancer patients

  2022cites this paper
• MYC-mediated silencing of miR-181a-5p promotes pathogenic Th17 responses by modulating AKT3-FOXO3 signaling

  2022cites this paper
• Aberrantly high activation of a FoxM1–STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers

  2021cites this paper
• The Clinicopathologic and Prognostic Significance of c-Myc Expression in Hepatocellular Carcinoma: A Meta-Analysis

  2021cites this paper
• Exosomal SNHG16 secreted by CSCs promotes glioma development via TLR7

  2021cites this paper
• A rare variant in EZH2 is associated with prostate cancer risk

  2021cites this paper
• Polyfunctionality of the CXCR4/CXCL12 axis in health and disease: Implications for therapeutic interventions in cancer and immune‐mediated diseases

  2021cites this paper
• RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming

  2021cites this paper
• Epigenetic silencing of miR-144/451a cluster contributes to HCC progression via paracrine HGF/MIF-mediated TAM remodeling

  2021cites this paper
• MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review

  2021cites this paper
• EZH2-mediated Epigenetic Silencing of miR-29/miR-30 targets LOXL4 and contributes to Tumorigenesis, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer

  2020cites this paper
• A miR-205-LPCAT1 axis contributes to proliferation and progression in multiple cancers.

  2020cites this paper
• PRMT1 Modulates Processing of Asthma-Related Primary MicroRNAs (Pri-miRNAs) into Mature miRNAs in Lung Epithelial Cells.

  2020cites this paper
• A Network Meta-Analysis on the Diagnostic Values of MiR-21/MiR-16/MiR-34a/let-7b-5p/let-7g/MiR-218-5p in Non-Small-Cell Lung Cancer

  2020cites this paper
• Non-Coding RNAs: Regulating Disease Progression and Therapy Resistance in Hepatocellular Carcinoma

  2020cites this paper
• Long non-coding RNA HOTAIR and HOTTIP as potential biomarkers for hepatitis C virus genotype 4-induced hepatocellular carcinoma

  2020cites this paper
• Hypoxia-sensitive long noncoding RNA CASC15 promotes lung tumorigenesis by regulating the SOX4/β-catenin axis

  2020cites this paper
• Functions and mechanisms of chemokine receptor 7 in tumors of the digestive system

  2020cites this paper
• No Easy Way Out for EZH2: Its Pleiotropic, Noncanonical Effects on Gene Regulation and Cellular Function

  2020cites this paper
• DNA methylation‐regulated and tumor‐suppressive roles of miR‐487b in colorectal cancer via targeting MYC, SUZ12, and KRAS

  2019cites this paper
• Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.

  2019cites this paper
• SDF-1/CXCR4 axis facilitates myeloid-derived suppressor cells accumulation in osteosarcoma microenvironment and blunts the response to anti-PD-1 therapy.

  2019cites this paper
• Utility of Combined EZH2, p-ERK1/2, p-STAT, and MYC Expression in the Differential Diagnosis of EZH2-positive Hodgkin Lymphomas and Related Large B-Cell Lymphomas

  2019cites this paper
• Liquid Biopsy in Hepatocellular Carcinoma

  2019cites this paper
• Dysregulation of EZH2/miR-138 axis contributes to drug resistance in multiple myeloma by downregulating RBPMS

  2018cites this paper
• Integrated network analysis to identify the key genes, transcription factors, and microRNAs involved in hepatocellular carcinoma.

  2018cites this paper
• LncRNA HOXA11‐AS promotes hepatocellular carcinoma progression by repressing miR‐214‐3p

  2018cites this paper
• CXCR7 Targeting and Its Major Disease Relevance

  2018cites this paper
• Interplay of miRNAs and Canonical Wnt Signaling Pathway in Hepatocellular Carcinoma

  2018cites this paper
• EGF-Mediated Overexpression of Myc Attenuates miR-26b by Recruiting HDAC3 to Induce Epithelial-Mesenchymal Transition of Lens Epithelial Cells

  2018cites this paper
• MiR‐106b regulates the apoptosis and tumorigenesis of hepatocellular carcinoma via targeting Zinc finger and BTB domain‐containing protein 7A (Zbtb7a)

  2018cites this paper
• MicroRNA-101a suppresses fibrotic programming in isolated cardiac fibroblasts and in vivo fibrosis following trans-aortic constriction.

  2018cites this paper
• O-GlcNAcylation promotes colorectal cancer metastasis via the miR-101-O-GlcNAc/EZH2 regulatory feedback circuit

  2018cites this paper
• In vivo genome-wide binding interactions of mouse and human constitutive androstane receptors reveal novel gene targets

  2018cites this paper
• CUDC-907 displays potent antitumor activity against human pancreatic adenocarcinoma in vitro and in vivo through inhibition of HDAC6 to downregulate c-Myc expression

  2018cites this paper
• MYC and DNMT3A‐mediated DNA methylation represses microRNA‐200b in triple negative breast cancer

  2018cites this paper
• MicroRNA-139 suppresses hepatocellular carcinoma cell proliferation and migration by directly targeting Topoisomerase I.

  2018cites this paper
• Tumor‐suppressive miR‐145 co‐repressed by TCF4‐β‐catenin and PRC2 complexes forms double‐negative regulation loops with its negative regulators in colorectal cancer

  2018cites this paper
• MYCN Silencing as Therapeutics for Neuroblastoma using RNA interference

  2018cites this paper
• MicroRNA-26a is a key regulon that inhibits progression and metastasis of c-Myc/EZH2 double high advanced hepatocellular carcinoma.

  2018cites this paper
• Molecular signatures in hepatocellular carcinoma: A step toward rationally designed cancer therapy

  2018cites this paper
• Nicotine associated breast cancer in smokers is mediated through high level of EZH2 expression which can be reversed by methyltransferase inhibitor DZNepA

  2018cites this paper
• Long noncoding RNA GAS5 promotes bladder cancer cells apoptosis through inhibiting EZH2 transcription

  2018cites this paper
• Long non-coding RNAs AC026904.1 and UCA1: a “one-two punch” for TGF-β-induced SNAI2 activation and epithelial-mesenchymal transition in breast cancer

  2018influential citation
• Knockdown of STMN1 enhances osteosarcoma cell chemosensitivity through inhibition of autophagy

  2017cites this paper
• ERK2-ZEB1-miR-101-1 axis contributes to epithelial-mesenchymal transition and cell migration in cancer.

  2017cites this paper
• miRNA-101-1 and miRNA-221 expressions and their polymorphisms as biomarkers for early diagnosis of hepatocellular carcinoma.

  2017cites this paper
• Identification of miRNA-7 by genome-wide analysis as a critical sensitizer for TRAIL-induced apoptosis in glioblastoma cells

  2017cites this paper
• c-Myc is Required for BRAFV600E-Induced Epigenetic Silencing by H3K27me3 in Tumorigenesis

  2017cites this paper
• MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation

  2017cites this paper
• Role of the long non-coding RNA HOTAIR in hepatocellular carcinoma

  2017cites this paper
• Identification of suitable reference genes for miRNA expression normalization in gastric cancer.

  2017cites this paper
• Long Noncoding RNAs as a Key Player in Hepatocellular Carcinoma

  2017cites this paper
• Combining Gene Expression and Interactions Data with miRNA Family Information for Identifying miRNA-mRNA Regulatory Modules

  2017cites this paper
• Identification of active miRNA promoters from nuclear run-on RNA sequencing

  2017cites this paper
• Interplay between the miRNome and the epigenetic machinery: Implications in health and disease

  2017cites this paper
• Etiology and Pathogenesis of Hepatocellular Carcinoma: Epigenetic Mechanisms

  2017cites this paper
• Dysregulation of the miR‐194–CUL4B negative feedback loop drives tumorigenesis in non‐small‐cell lung carcinoma

  2017cites this paper
• MiR‐101 and doxorubicin codelivered by liposomes suppressing malignant properties of hepatocellular carcinoma

  2017influential citation
• MicroRNA-101 inhibits invasion and angiogenesis through targeting ITGA3 and its systemic delivery inhibits lung metastasis in nasopharyngeal carcinoma

  2017cites this paper
• Prognostic significance of microRNA-101 in solid tumor: A meta-analysis

  2017cites this paper
• Clinicopathological significance of miR-101-3p and c-myc mRNA expression in diffused large B-cell lymphoma.

  2017cites this paper
• Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation: Impact on Regulation of Notch Pathway.

  2017cites this paper
• Integrated Loss of miR-1/miR-101/miR-204 Discriminates Metastatic from Nonmetastatic Penile Carcinomas and Can Predict Patient Outcome.

  2016cites this paper
• MicroRNA regulatory pathway analysis identifies miR-142-5p as a negative regulator of TGF-β pathway via targeting SMAD3

  2016cites this paper
• Epigenetics in liver disease: from biology to therapeutics

  2016cites this paper
• MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma

  2016cites this paper
• Disruption of the EZH2/miRNA/β-catenin signaling suppresses aerobic glycolysis in glioma

  2016cites this paper
• Differential expression of enhancer of zeste homolog 2 (EZH2) protein in small cell and aggressive B-cell non-Hodgkin lymphomas and differential regulation of EZH2 expression by p-ERK1/2 and MYC in aggressive B-cell lymphomas

  2016cites this paper
• Yin Yang 1‐mediated epigenetic silencing of tumour‐suppressive microRNAs activates nuclear factor‐κB in hepatocellular carcinoma

  2016cites this paper
• KDM4B-mediated epigenetic silencing of miRNA-615-5p augments RAB24 to facilitate malignancy of hepatoma cells

  2016cites this paper
• Hepatoepigenetic Alterations in Viral and Nonviral-Induced Hepatocellular Carcinoma

  2016cites this paper
• Hepatocellular carcinoma diagnosis: Circulating microRNAs emerge as robust biomarkers.

  2016cites this paper
• MicroRNA-101 regulated transcriptional modulator SUB1 plays a role in prostate cancer

  2016cites this paper
• Developmental epigenetic programming of adult germ cell death disease: Polycomb protein EZH2-miR-101 pathway.

  2016cites this paper
• Knockdown of lncRNA-ATB suppresses autocrine secretion of TGF-β2 by targeting ZNF217 via miR-200c in keloid fibroblasts

  2016cites this paper
• Epigenetically regulated miR-145 suppresses colon cancer invasion and metastasis by targeting LASP1

  2016cites this paper
• Hepatitis C virus and its protein NS4B activate the cancer-related STAT3 pathway via the endoplasmic reticulum overload response

  2016cites this paper
• A double-negative feedback loop between EZH2 and miR-26a regulates tumor cell growth in hepatocellular carcinoma.

  2016influential citation
• Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer

  2016cites this paper